Sociological research of the men’s androgenic alopecia problem

Authors

DOI:

https://doi.org/10.15587/2519-4852.2024.302322

Keywords:

psychodermatology, psychotrichology androgenic alopecia, sociological research, questionnaires, pharmacotherapy, dermatocosmetic products

Abstract

Diseases of the skin and its appendages currently occupy one of the leading places in terms of prevalence. In addition, today the relationship between dermatopathologies and the psychoemotional state of people and vice versa is clearly monitored. Psychodermatology is engaged in the study of exactly this regularity. One of the most common trichological diseases is androgenic alopecia, which is characterized by excessive hair loss under the influence of androgens in individuals with a hereditary predisposition. Androgenic alopecia is often accompanied by secondary mental disorders, which significantly impair the quality of people’s life. It is relevant to conduct sociological research of this problem among men of all age groups. Such research will reveal the level of influence of androgenic alopecia on the psychoemotional state of men who may be potential consumers of medicines and dermatocosmetics.

The aim of the work was to conduct a sociological study to establish the impact of androgenic alopecia on the psychoemotional state of men and their readiness for pharmacotherapy.

Materials and methods. Sociological research was conducted from 01.03.2019 to 31.08.2019 by surveying 150 men aged 18 to 66. Respondents were visitors to pharmacies in the Ivano-Frankivsk and Chernivtsi regions of Ukraine, who gave written consent to participate in the survey. Only persons with visible manifestations of androgenic alopecia according to the Norwood scale were included in the survey. All respondents were divided into the following age groups: from 18 to 20 years old, from 21 to 30 years old, from 31 to 40 years old, from 41 to 50 years old, from 51 to 60 years old, from 61 years old and older. The distribution was carried out to segment the target market. The results of the study were displayed as percentages with 95 % confidence intervals. Statistical analysis was performed using R version 4.1.2 (R Core Team (2021).

The results. According to the results of the sociological study, 48.7 % of interviewed men consider that androgenic alopecia is a problem which can affect the emotional state and, so, the quality of life. As a result, about 90 % of the respondents indicated that they need to expand the assortment of effective remedies to solve this problem on the pharmaceutical market of Ukraine, of which 36.7 % are ready to pay for a course of effective pharmacotherapy from 200 to 500 hryvnias.

Conclusions. The obtained results confirm that androgenic alopecia has a negative effect on the psychoemotional state of men and worsens their quality of life. To solve the problem of androgenic alopecia, men are interested in using effective medicinal or dermatocosmetic products

Author Biographies

Mariana Fedorovska, Lesya Ukrainka Volyn National University

Doctor of Pharmaceutical Sciences, Professor

Department of Pharmacу and Pharmacology

Inna Yarema, Ivano-Frankivsk National Medical University

PhD, Assistant

Department of Pharmaceutical Management, Drug Technology and Pharmacognosy

Anna Sinichenko, Ivano-Frankivsk National Medical University

PhD, Аssistant

Department of Pharmaceutical Management, Technology of Drugs and Pharmacognosy

Olena Hlushchenko, O. Bogomolets National Medical University

PhD, Associate Professor

Department of Pharmaceutical and Industrial Technology of Medicines

Oksana Strus, Danylo Halytsky Lviv National Medical University

Doctor of Pharmaceutical Sciences, Associate Professor

Department of Drug Technology and Biopharmaceutics

References

  1. Chernyshov, P. V. (2019). The Evolution of Quality of Life Assessment and Use in Dermatology. Dermatology, 235 (3), 167–174. https://doi.org/10.1159/000496923
  2. Spirina, І. D., Shornikov, А. V., Fawzy, Ye. S., Shevchenko, Yu. M., Kovalenko, T. Yu. (2018). Mental disorders in patients with skinpathology. Dermatovenerolohiia. Kosmetolohiia. Seksopatolohiia, 1-4, 99–104.
  3. Kutasevych, Ya. F., Jafferany, M., Sviatenko, T. V., Bilovol, A. M., Bolotna, L. A. et al. (2018). Psychodermatology in Ukraine: modern view at the problem. Dermatolohiia ta venerolohiia, 4 (82), 8–12.
  4. Leite Júnior, A., Katzer, T., Ramos, D. (2017). Three cases of hair loss analyzed by the point of view of the analytical psychology. International Journal of Trichology, 9 (4), 177–180. https://doi.org/10.4103/ijt.ijt_106_16
  5. Tohid, H., Shenefelt, P. D., Burney, W. A., Aqeel, N. (2019). Psychodermatology: An Association of Primary Psychiatric Disorders With Skin. Revista Colombiana de Psiquiatría, 48 (1), 50–57. https://doi.org/10.1016/j.rcp.2017.07.002
  6. Aymedov, K. V. (2016). Psychodermatology – biopsychosocial approach. Journal of Education, Health and Sport, 6 (12), 941–950.
  7. Harth, W., Blume‐Peytavi, U. (2012). Psychotrichology: psychosomatic aspects of hair diseases. JDDG: Journal Der Deutschen Dermatologischen Gesellschaft, 11 (2), 125–135. https://doi.org/10.1111/j.1610-0387.2012.08034.x
  8. Moattari, C. R., Jafferany, M. (2021). Psychological Aspects of Hair Disorders: Consideration for Dermatologists, Cosmetologists, Aesthetic, and Plastic Surgeons. Skin Appendage Disorders, 8 (3), 186–194. https://doi.org/10.1159/000519817
  9. Jafferany, M., Patel, A. (2019). Trichopsychodermatology: The Psychiatric and Psychosocial Aspects of Hair Disorders. Dermatologic Therapy, 33 (1). https://doi.org/10.1111/dth.13168
  10. Zhyvylko, V. V., Yefremenko, T. O. (2016). Alopecia in women as dermatology and psychosomatic disorder. Visnyk morskoi medytsyny, 3, 121–127.
  11. Vozianova, S. V., Bolotna, L. A., Sarian, O. I. (2022). Vypadinnia volossia u zhinok: patofiziolohichni, diahnostychni i terapevtychni aspekty. Reproductive health of woman, 5 (60), 26–33.
  12. Lolli, F., Pallotti, F., Rossi, A., Fortuna, M. C., Caro, G., Lenzi, A. et al. (2017). Androgenetic alopecia: a review. Endocrine, 57 (1), 9–17. https://doi.org/10.1007/s12020-017-1280-y
  13. Aukerman, E. L., Jafferany, M. (2022). The psychological consequences of androgenetic alopecia: A systematic review. Journal of Cosmetic Dermatology, 22 (1), 89–95. https://doi.org/10.1111/jocd.14983
  14. Cash. (1999). The psychosocial consequences of androgenetic alopecia: a review of the research literature. British Journal of Dermatology, 141 (3), 398–405. https://doi.org/10.1046/j.1365-2133.1999.03030.x
  15. Cash, T. F. (1992). The psychological effects of androgenetic alopecia in men. Journal of the American Academy of Dermatology, 26 (6), 926–931. https://doi.org/10.1016/0190-9622(92)70134-2
  16. Kranz, D. (2011). Young men’s coping with androgenetic alopecia: Acceptance counts when hair gets thinner. Body Image, 8 (4), 343–348. https://doi.org/10.1016/j.bodyim.2011.06.006
  17. Doma, H., Gaber, M. (2021). The psychosocial effect of androgenetic alopecia in males and females. Menoufia Medical Journal, 34 (1), 87–92. https://doi.org/10.4103/mmj.mmj_268_19
  18. Cash, T. F., Price, V. H., Savin, R. C. (1993). Psychological effects of androgenetic alopecia on women: Comparisons with balding men and with female control subjects. Journal of the American Academy of Dermatology, 29 (4), 568–575. https://doi.org/10.1016/0190-9622(93)70223-g
  19. Yazıcı, E., Erol, A. (2015). Psychiatric approach to alopecia. Turkiye Klinikleri Cosmetic Dermatology, 8, 73–78.
  20. Gupta, M., Mysore, V. (2016). Classifications of patterned hair loss: a review. Journal of Cutaneous and Aesthetic Surgery, 9 (1), 3–12. https://doi.org/10.4103/0974-2077.178536
  21. Thulin, M. (2014). The cost of using exact confidence intervals for a binomial proportion. Electronic Journal of Statistics, 8 (1), 817–840. https://doi.org/10.1214/14-ejs909
Sociological research of the men’s androgenic alopecia problem

Downloads

Published

2024-04-30

How to Cite

Fedorovska, M., Yarema, I., Sinichenko, A., Hlushchenko, O., & Strus, O. (2024). Sociological research of the men’s androgenic alopecia problem. ScienceRise: Pharmaceutical Science, (2 (48), 29–35. https://doi.org/10.15587/2519-4852.2024.302322

Issue

Section

Pharmaceutical Science